FDA Approves Keytruda for Early-Stage TNBC

Options
Moderators
Moderators Member Posts: 25,912
edited July 2022 in Triple-Negative Breast Cancer
FDA Approves Keytruda for Early-Stage Triple-Negative Breast Cancer
July 27, 2021
The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...
· Share on FacebookShare on Twitter

Categories